JMJohn H. McDermott

John H. McDermott

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


John H. McDermott has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Headspace Volatile Organic Compound (VOC) Profiling of Infected and Non-Infected Wound Swabs—A Pilot Study

    by Shane Fitzgerald, Linda Holland, Melissa Finnegan, Kellie Fortune, Brid Cooney, Eoghan O’Neill, John H. McDermott, Seamus Sreenan, Tommy Kyaw-Tun, Aoife Morrin

    Infections of chronic wounds are a major healthcare burden worldwide and can lead to poor health outcomes such as amputations of limbs and death. Detecting infections early significantly increases the effectiveness of therapeutic interventions. Screening of volatile organic compounds (VOCs) emitted from wound swab samples can potentially serve as a highly specific indicator of infection. Profiling of VOCs from infected and non-infected wounds was carried out. Swab samples were collected from 26 wounds from 23 patients (n = 20 diabetic patients; n = 3 non-diabetic patients). There were 16 wounds sampled that were clinically determined as infected, and 10 as non-infected. Headspace-solid phase microextraction gas chromatography-mass spectrometry (HS-GC-MS) was used to rapidly sample and detect VOCs from the swabs following a short incubation period. A total of 42 compounds were identified and included for analysis. Infected wounds emitted more diverse VOCs compared to non-infected wounds. Higher numbers of compounds with significantly higher abundances were detected from severely infected wounds compared to less severely infected wounds. Abundances of short-chain fatty acids (SCFAs) and branched-chain fatty acids (BCFAs) were found to be the strongest discriminators of infected from non-infected wounds. Further validation is needed, but the results of this pilot study highlight the potential of detecting these compounds as a highly specific and targeted route to predicting or detecting wound infections in the future.


  • Open Access

    The impact of machine learning on the prediction of diabetic foot ulcers – A systematic review

    by Teagan Weatherall, Pinar Avsar, Linda Nugent, Zena Moore, John H. McDermott, Seamus Sreenan, Hannah Wilson, Natalie L. McEvoy, Rosemarie Derwin, Paul Chadwick, et al.


  • Open Access

    Thematic Daily Sleep Routine Analysis of Adults Not in Employment Living with Type 2 Diabetes Mellitus

    by Rachael M. Kelly, John H. McDermott, Andrew N. Coogan

    Background: Day-to-day variations in sleep timing have been associated with poorer glycemic control in type 2 diabetes mellitus, although the factors that influence this sleep timing variability are poorly understood. Methods: Daily routines of sleep in a sample of seventeen adults with type 2 diabetes mellitus who were either retired or not currently working were examined qualitatively through the application of semi-structured interviews and a thematic analysis of the resulting transcripts. Results: Four themes were identified: “Consistent Sleeping Patterns”, “Fluctuating Sleep Timing”, “Night-Time Disruptions” and “Lasting Effort Needed with Type Two Diabetes Mellitus”. The subthemes reflected that many participants had consistent sleep schedules across the seven-day week, but that a desire to maintain a sense of normality, household routines, television schedules and socializing were associated with different sleep timing on weekends. Active disease monitoring and timed medication taking were not identified as important factors in shaping sleep timing. Nocturia, stress and rumination were identified as important factors linked to disrupted sleep. Sleep was not reported as an issue discussed during routine clinical care. Conclusion: Sleep timing in participants appears to be driven by interacting psychosocial and physiological factors, although active disease management does not emerge as a major influence on sleep schedules.


  • Open Access

    Differences in Sleep Offset Timing between Weekdays and Weekends in 79,161 Adult Participants in the UK Biobank

    by Rachael M. Kelly, John H. McDermott, Andrew N. Coogan

    Variability in the timing of daily sleep is increasingly recognized as an important factor in sleep and general physical health. One potential driver of such daily variations in sleep timing is different work and social obligations during the “working week” and weekends. To investigate the nature of weekday/weekend differences in the timing of sleep offset, we examined actigraphy records of 79,161 adult participants in the UK Biobank who wore an actiwatch for 1 week. The time of sleep offset was found to be on average 36 min later on weekends than on weekdays, and when this difference was expressed as an absolute value (i.e., irrespective of sleep offset being either later or earlier on weekends), it was 63 min. Younger age, more socioeconomic disadvantage, currently being in employment, being a smoker, being male, being of non-white ethnicity and later chronotype were associated with greater differences in sleep offset between weekdays and weekend days. Greater differences in sleep offset timing were associated with age-independent small differences in cardiometabolic health indicators of BMI and diastolic blood pressure, but not HbA1c or systolic blood pressure. In a subset of participants with Type 2 Diabetes Mellitus, weekday/weekend sleep offset differences were associated weakly with BMI, systolic blood pressure and physical activity. Overall, this study demonstrates potentially substantive differences in sleep offset timings between weekdays and weekends in a large sample of UK adults, and that such differences may have public health implications.


  • Open Access

    A silent myocardial infarction in the diabetes outpatient clinic: case report and review of the literature

    by M S Draman, H Thabit, T J Kiernan, J O'NEill, S Sreenan, J H McDermott

    Summary: Silent myocardial ischaemia (SMI), defined as objective evidence of myocardial ischaemia in the absence of symptoms, has important clinical implications for the patient with coronary artery disease. We present a dramatic case of SMI in a diabetes patient who attended annual review clinic with ST elevation myocardial infarction. His troponin was normal on admission but raised to 10.7 ng/ml (normal <0.5) when repeated the next day. His angiogram showed diffused coronary artery disease. We here discuss the implications of silent ischaemia for the patient and for the physician caring for patients with diabetes. Learning points: Silent myocardial ischaemia (SMI) is an important clinical entity. SMI is common and occurs with increased frequency in patients with diabetes. SMI is an independent predictor of mortality. Recognition may lead to early intervention.